Cardiovascular

Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Products for Cardiovascular
- Acute Phase Reactants(10)
- Angina(12)
- Arrhythmia(67)
- Atherosclerosis(67)
- Chronic Kidney Disease(12)
- Coagulation & Hemostasis(88)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(6)
- Endothelium(21)
- Erythrocytes & Hemoglobin(33)
- Heart Failure(25)
- Hypertension(138)
- Hypotension(13)
- Lipoproteins(45)
- Myocardial Contractility(24)
- Myocardial Hypertrophy(19)
- Myocardial Infarction(47)
- Others(1)
- Serum Proteins(5)
- Smooth Muscle Cells(21)
- Storage & Transport(5)
- Stroke(31)
- Thrombosis(43)
- Vasoconstriction(38)
- Vasodilation(96)
- Cardiomyopathy(5)
- Cholesterol Metabolism(37)
- Cat.No. Product Name Information
-
GP10027
heparin cofactor II precursor fragment [Homo sapiens]
Thrombin inhibitor
-
GP10040
heparin cofactor II precursor (SERPIND1) fragment [Homo sapiens]
Thrombin inhibitor
-
GP10009
Papilostatin-2
Papilostatin-2
-
GP10011
Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial Cell
-
GP10062
Endothelin-1 (1-15), amide, human
-
GP10117
Endostatin (84-114)-NH2 (JKC367)
-
GP10091
Vasonatrin Peptide (1-27)
Vasonatrin Peptide (1-27), (C124H198N36O36S3), a peptide with the sequence H2N-GLSKGCFGLKLDRIGSMSGLGCNSFRY-OH, MW= 2865.4.
-
GP10071
BNP (1-32), human
-
GP10061
Atrial Natriuretic Factor (1-29), chicken
Atrial Natriuretic Factor (1-29), chicken, (C130H223N51O41S5), a peptide with the sequence H2N-SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH-OH, MW= 3316.8.
-
GP10072
Pro-Adrenomedullin (153-185), human
Vasodilator
-
GP10053
Prothrombin (474-477) [Mus musculus]
-
GP10134
coagulation factor II (thrombin) B chain fragment [Homo sapiens]
-
GP10120
Angiotensin 1/2 + A (2 - 8)
Vasoconstrictor
-
GP10012
Angiotensin 1/2 (1-8) amide
Vasoconstrictor
-
GP10144
Angiotensin 1/2 (1-7) amide
-
GP10099
amyloid A protein fragment [Homo sapiens]
Apolipoproteins related to HDL in plasma
-
GP10045
Angiotensin 1/2 (2-7)
Vasoconstrictor
-
GP10079
Angiotensin 1/2 (5-7)
-
GP10067
Angiotensin 1/2 (1-6)
-
GP10074
Angiotensin 1/2 (1-5)
-
GP10085
Thrombin Receptor Activator for Peptide 5 (TRAP-5)
-
GP10059
Acetyl Angiotensinogen (1-14), porcine
-
GP10127
Cadherin Peptide, avian
Role in cell adhesion
-
GP10115
GTP-Binding Protein Fragment, G alpha
-
GP10089
Platelet Membrane Glycoprotein IIB Peptide (296-306)
Inhibits platelet aggregation
-
GP10121
Ac-Endothelin-1 (16-21), human
-
GP10137
ANP (1-11), rat
-
GP10025
Angiotensin 1/2 (1-9)
-
GP10113
Adrenomedullin (1-12), human
An N-terminal fragment of adrenomedullin
-
GP10010
COG 133
-
GP10119
Gap 27
A connexin-mimetic peptide
-
GP10107
Gap 26
-
GP10110
Angiotensin III (human, mouse)
An agonist at AT1 and AT2 receptors
-
GP10023
Angiotensin II
An agonist at AT1 and AT2 receptors
-
GP10077
Angiotensin (1-7)
-
GP10065
Endomorphin-1
-
GP10087
Angiotensin I (human, mouse, rat)
-
GC20172
N-Isopropylphthalimide
-
GC52497
Lactosylceramide (porcine RBC)
A sphingolipid
-
GC52478
Telmisartan Acyl-β-D-Glucuronide (hydrate)
A major metabolite of telmisartan
-
GC52460
tcY-NH2 (trifluoroacetate salt)
A peptide antagonist of PAR4
-
GC52438
CGRP (8-37) (mouse, rat) (trifluoroacetate salt)
A CGRP receptor antagonist
-
GC52436
TRAP-6 amide (trifluoroacetate salt)
A peptide PAR1 agonist
-
GC52427
Apelin-12 (human, mouse, rat, bovine) (acetate)
An endogenous agonist of the APJ receptor
-
GC52424
Bradykinin Fragment (1-5) (trifluoroacetate salt)
A metabolite of bradykinin
-
GC52415
Angiotensin A (trifluoroacetate salt)
An AT1 and AT2 receptor agonist and active metabolite of angiotensin II
-
GC52404
γ-Glu-Phe (trifluoroacetate salt)
A dipeptide with metabolism-altering activity
-
GC52400
γ-Glu-Ala (trifluoroacetate salt)
A dipeptide
-
GC52390
Spexin 1 (human, mouse, rat, bovine) (acetate)
An endogenous peptide and agonist of GAL2 and GAL3
-
GC52389
Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)
A synthetic peptide fragment of caveolin-1
-
GC52388
[D-Lys3]-GHRP-6 (trifluoroacetate salt)
An antagonist of GHS-R1a
-
GC52384
NFAT Inhibitor (cell-permeable) (trifluoroacetate salt)
A cell-permeable form of NFAT inhibitor
-
GC52359
ATX-100
An ionizable cationic lipid
-
GC52351
Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide
A biotinylated and citrullinated α-enolase peptide
-
GC52342
P4pal10 (trifluoroacetate salt)
A PAR4 and FPR2 antagonist and an FFAR2 agonist
-
GC52327
Ciraparantag (trifluoroacetate salt)
An anticoagulant reversal agent
-
GC52324
3-(3-Hydroxyphenyl)propionic Acid sulfate
A metabolite of certain phenols and glycosides
-
GC52318
Oleic Acid-13C5
An internal standard for the quantification of oleic acid
-
GC52310
L-Arginine-13C6 (hydrochloride)
An internal standard for the quantification of L-arginine
-
GC52303
Ethyl Mycophenolate
A potential impurity found in commercial preparations of mycophenolate mofetil
-
GC52281
Losartan Azide
A potential impurity in commercial preparations of losartan
-
GC52254
Thrombin-Sensitive Peptide (ammonium acetate salt)
A synthetic peptide containing a thrombin-releasable quencher
-
GC52250
Mevalonate (lithium salt)
An intermediate in the mevalonate pathway
-
GC52233
SSPalmO-Phe
An ionizable cationic self-degradable SSPalm
-
GC52221
Eleclazine
An inhibitor of the cardiac late INa
-
GC52193
Eptifibatide
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.
-
GC52180
WAY-169916
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity.
-
GC52177
Perphenazine Sulfoxide
-
GC52150
Velaresol
-
GC52149
306-O12B
-
GC52145
Bradykinin (human, mouse, rat, bovine) (acetate)
-
GC52132
N-desmethyl Diltiazem (hydrochloride)
-
GC52125
T-1095
T-1095 is a selective and orally active Na+-glucose cotransporter (SGLT) inhibitor with IC50s of 22.8 ?M and 2.3 ?M for human SGLT1 and SGLT2, respectively.
-
GC52122
2’-Deoxyadenosine-5’-diphosphate (sodium salt)
A nucleotide diphosphate
-
GC52112
Stercobilinogen (technical grade)
A metabolite of bilirubin and a precursor in the biosynthesis of stercobilin
-
GC52084
YSK05
YSK05 is a pH-sensitive cationic lipid. YSK05 improves the intracellular trafficking of non-viral vectors. YSK05-MEND shows significantly good gene silencing activity and hemolytic activity. YSK05 overcomes the suppression of endosomal escape by PEGylation. YSK05 effectively enhances siRNA delivery both in vitro and in vivo.
-
GC52069
N-Methyl-4-pyridone-5-carboxamide
A metabolite of nicotinic acid and a uremic toxin
-
GC52065
4-Methoxyphenyl-β-D-Glucopyranoside
An aryl glycoside with ice recrystallization inhibitory activity
-
GC52058
Acebutolol
Acebutolol is an orally active β1 adrenergic receptor (β1AR) antagonist.
-
GC52052
Dofetilide N-oxide
-
GC52051
Desglymidodrine
Desglymidodrine (ST 1059), the active metabolite of Midodrine, is a selective α1-adrenoceptor agonist.
-
GC52048
3-hydroxy-4-Methoxyphenethylamine (hydrochloride)
3-hydroxy-4-Methoxyphenethylamine (hydrochloride) is a catecholamine compound that has an inhibitory effect on dihydropteridine reductase.
-
GC52045
N-desmethyl Azelastine
N-desmethyl Azelastine is a main active metabolite of Azelastine that is oxidatively metabolized by the cytochrome P450 enzyme system with a protein binding rate of 97% and an elimination half-life of 54 hours.
-
GC52035
Esmolol Acid (hydrochloride)
An active metabolite of esmolol
-
GC52034
Quinaprilat
Quinaprilat is an orally active non-mercapto Angiotensin Converting Enzyme (ACE) inhibitor, the active metabolite of Quinapril.
-
GC52023
Alfuzosin-d7
An internal standard for the quantification of alfuzosin
-
GC52019
Norpropranolol (hydrochloride)
An active metabolite of propranolol
-
GC52011
Stearic Acid glycidyl ester
An esterified form of stearic acid
-
GC52007
N-hydroxylamine Dapsone
An active metabolite of dapsone
-
GC52006
CB-096
An inhibitor of RAN translation
-
GC52005
Triazolomethylindole-3-acetic Acid
A metabolite of rizatriptan
-
GC49916
Lys-(Des-Arg9, Leu8)-Bradykinin (trifluoroacetate salt)
A bradykinin B1 receptor antagonist
-
GC49890
β-Glycerophosphate-d5 (sodium salt hydrate)
An internal standard for the quantification of β-glycerophosphate
-
GC49885
BQ-3020 (trifluoroacetate salt)
A peptide ETB receptor antagonist
-
GC49884
Trigonelline-d3 (chloride)
An internal standard for the quantification of trigonelline
-
GC49882
Hemokinin 1 (human) (trifluoroacetate salt)
A peptide agonist of NK1 receptors
-
GC49880
Bradykinin (trifluoroacetate salt)
An endogenous vasodilator
-
GC49873
Protectin D1 methyl ester
An esterified form of protectin D1
-
GC49866
Desmethyl Carvedilol
An active metabolite of carvedilol
-
GC49863
Cytarabine 5′-monophosphate
An active metabolite of cytarabine